- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01203670
Renal and Digestive Tolerance of a Food Supplement, Phytalgic, in Elderly Volunteers - A Multicentric Open Trial
September 21, 2010 updated by: Phythea
The aim of the study is to evaluate renal and digestive tolerance of a food supplement, phytalgic, on elderly volunteers.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
50
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Bordeaux, France, 33076
- Département de Pharmacologie Clinique - Université Victor Segalen Bordeaux 2 - CHU de Bordeaux
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
70 years to 87 years (Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- 70 years old minimum
- Satisfying general health judged by principal investigator
- Pain and /or stifness associated with arthritis
- Regular used of analgesics and/or non-steroidal anti-inflammatory drugs (NSAIDs)
Digestive tolerance biomarkers
- ASAT : Men < 150 UI/L - Women < 100 UI/L
- ALAT : Men < 180 UI/l - Women < 130 UI:l
- Gamma GT Men < 180 UI/l - Gamma GT Women < 100 UI/l
- Amylase < 250 UI/l
- Lipase < 750 UI/l
- Renal tolerance biomarker: Glomerular filtration rate (GFR)superior or equal to 60 mL /min / 1.73m3 - calculated with the "Modification of the Diet in Renal Diseases" formula
Exclusion Criteria:
- Inflammatory arthritis
- Allergy to any constituents of the study drug
- Types 2 diabetes
- Not legally fit to participate
- Any treatment able to modify determined biological parameters
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Soft capsules of Phytalgic
Phytalgic is a food supplement.
Its galenic form is soft capsule.
|
Volunteers have to take three soft capsules per day, one in the morning and two in the evening.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Renal tolerance by Glomerular filtration rate (GFR) determination; Digestive tolerance by Aspartate Amino transferase (ASAT), Alanine Amino Transferase (ALAT), gamma Glutamyl Transpeptidase (gamma GT), lipase and amylase determination
Time Frame: 168 days
|
168 days
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Quality of life determined by Western Ontario and McMaster universities (WOMAC)Visual Analogue Scale(VAS)
Time Frame: 168 days
|
168 days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Alain JACQUET, MD, Département de pharmacologie Clinique - Université Victor Segalen Bordeaux 2 - Centre Hospitalo-Universitaire de Bordeaux
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Completion (Actual)
December 1, 2009
Study Registration Dates
First Submitted
September 15, 2010
First Submitted That Met QC Criteria
September 15, 2010
First Posted (Estimate)
September 16, 2010
Study Record Updates
Last Update Posted (Estimate)
September 22, 2010
Last Update Submitted That Met QC Criteria
September 21, 2010
Last Verified
September 1, 2010
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- PHYTHEA-e437-950
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Renal Tolerance
-
Jeffrey Veale, MDOneLegacy FoundationRecruitingTolerance | Renal Transplant Rejection | Kidney TransplantUnited States
-
National Institute of Allergy and Infectious Diseases...Immune Tolerance Network (ITN)CompletedKidney Transplantation | Renal Transplant | Renal Transplantation | Transplant Rejection | Transplant ToleranceUnited States
-
Alcon ResearchNOVARTIS BIOCIENCIAS S/ACompleted
-
University of Oslo School of PharmacyCompletedRenal Transplant Recipients | Posttransplant Diabetes Mellitus | Posttransplant Impaired Glucose ToleranceNorway
-
Barts & The London NHS TrustWithdrawnRenal Transplant FailureUnited Kingdom
-
Mead Johnson NutritionBaylor College of MedicineCompleted
-
University of Illinois at Urbana-ChampaignCompleted
-
Société des Produits Nestlé (SPN)RecruitingToleranceUnited Kingdom
-
Liquid I.V.University of MemphisNot yet recruiting
-
Abbott NutritionCompleted
Clinical Trials on Phytalgic
-
Université Victor Segalen Bordeaux 2laboratoire Phythea, FranceCompleted